Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487231 | 0.79 | MAPK1 (0.48) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL28006379 | 0.78 | MAPK1 (0.40) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL6270358 | 0.75 | MAPK1 (0.44) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL131978 | 0.74 | MAPK1 (0.44) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL135667 | 0.74 | MAPK1 (0.56) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL2027830 | 0.73 | CA1 (0.41) | MAPK1ALDH1A1KMT2AGAAKDM4E | |
| SCHEMBL183489 | 0.73 | KIF11 (0.40) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL27290020 | 0.72 | CES1 (0.41) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL7056377 | 0.71 | MAPK1 (0.41) | CES1KCNN4MAPK1ALDH1A1ALOX15 | |
| SCHEMBL11110723 | 0.71 | MAPK1 (0.36) | CES1KCNN4MAPK1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107002293-B | Sequencing by synthesis using pulsed readout optics | 艾比斯生物科学公司 | 2020-12-08 | — | — | CN | claimed |
| US-20200123605-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. | 2020-04-23 | — | — | US | claimed |
| EP-3194643-B1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES INC (US) | 2020-02-19 | — | — | EP | claimed |
| US-10550428-B2 | Sequencing by synthesis using pulse read optics | IBIS BIOSCIENCES, INC. (US) | 2020-02-04 | — | — | US | claimed |
| US-20170247755-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. | 2017-08-31 | — | — | US | claimed |
| EP-3194643-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | Ibis Biosciences, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| WO-2016044391-A1 | SEQUENCING BY SYNTHESIS USING PULSE READ OPTICS | IBIS BIOSCIENCES, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| US-8975216-B2 | Articles having localized molecules disposed thereon and methods of producing same | PACIFIC BIOSCIENCES OF CALIFORNIA (US) | 2015-03-10 | — | — | US | claimed |
| EP-2231670-A2 | PROCESS FOR THE PREPARATION OF 2-(PRIMARY/SECONDARY AMINO)HYDROCARBYL)- CARBAMOYL-7-OXO-2,6-DIAZA-BICYCLOÝ3.2.0.¨HEPTANE-6-SULFONIC ACID DERIVATIVES | Basilea Pharmaceutica AG (CH) | 2010-09-29 | — | — | EP | claimed |
| JP-2009532032-A | — | — | 2009-09-10 | — | — | JP | claimed |
| EP-2002019-A4 | ARTICLES HAVING LOCALIZED MOLECULES DISPOSED THEREON AND METHODS OF PRODUCING SAME | PACIFIC BIOSCIENCES CALIFORNIA (US) | 2009-07-15 | — | — | EP | claimed |
| WO-2009071638-A2 | PROCESS FOR THE PREPARATION OF 2-(PRIMARY/SECONDARY AMINO)HYDROCARBYL)- CARBAMOYL-7-OXO-2,6-DIAZA-BICYCLO[3.2.0.]HEPTANE-6-SULFONIC ACID DERIVATIVES | BASILEA PHARMACEUTICA AG (CH) | 2009-06-11 | — | — | WO | claimed |
| EP-2002019-A2 | ARTICLES HAVING LOCALIZED MOLECULES DISPOSED THEREON AND METHODS OF PRODUCING SAME | Pacific Biosciences of California, Inc. (US) | 2008-12-17 | — | — | EP | claimed |
| US-20080009007-A1 | CONTROLLED INITIATION OF PRIMER EXTENSION | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2008-01-10 | — | — | US | claimed |
| WO-2007123763-A2 | ARTICLES HAVING LOCALIZED MOLECULES DISPOSED THEREON AND METHODS OF PRODUCING SAME | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2007-11-01 | — | — | WO | claimed |
| US-20070238679-A1 | Articles having localized molecules disposed thereon and methods of producing same | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2007-10-11 | — | — | US | claimed |
| US-5143854-A | LARGE SCALE PHOTOLITHOGRAPHIC SOLID PHASE SYNTHESIS OF POLYPEPTIDES AND RECEPTOR BINDING SCREENING THEREOF | AFFYMAX TECHNOLOGIES N.V. (AN) | 1992-09-01 | — | — | US | claimed |
| US-20240190894-A1 | CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | FOGHORN THERAPEUTICS INC. | 2024-06-13 | — | — | US | disclosed |
| EP-0292808-A2 | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | BAYER AG (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0284954-A2 | Cephalosporinderivatives, process for their preparation and their use in pharmaceutical products | BAYER AG (DE) | 1988-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190894-A1 | CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | CS, SMARCC2, SMARCC1 | CES1 629/4885KCNN4 2735/4885MAPK1 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.